Aegerion Pharma Inc (AEGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2010 | 12-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||
| Net Income | -14,254 | -12,196 | -25,035 |
| Depreciation Amortization | 10 | 28 | 24 |
| Accounts payable and accrued liabilities | 1,730 | -425 | -744 |
| Other Working Capital | 1,542 | -813 | -279 |
| Other Operating Activity | 2,473 | 2,873 | 4,044 |
| Operating Cash Flow | $-8,499 | $-10,532 | $-21,990 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -12 | N/A | N/A |
| Investing Cash Flow | $-12 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 7,500 | 5,000 | 16,340 |
| Common Stock Issued | 50,801 | N/A | N/A |
| Other Financing Activity | -7,118 | -2,044 | -9,737 |
| Financing Cash Flow | $51,183 | $2,956 | $6,602 |
| Beginning Cash Position | 1,429 | 9,005 | 24,393 |
| End Cash Position | 44,101 | 1,429 | 9,005 |
| Net Cash Flow | $42,672 | $-7,576 | $-15,388 |
| Free Cash Flow | |||
| Operating Cash Flow | -8,499 | -10,532 | -21,990 |
| Capital Expenditure | -12 | N/A | N/A |
| Free Cash Flow | -8,511 | -10,532 | -21,990 |